Metabolic syndrome and venous thromboembolism : the role of abdominal obesity and sex differences
(2026) In Journal of Thrombosis and Thrombolysis- Abstract
Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, including abdominal obesity, insulin resistance, dyslipidemia, and hypertension. Its association with venous thromboembolism (VTE) has been inconsistently reported. We investigated the association between MetS and VTE, and the influence of sex and abdominal obesity. We included 12,788 middle-aged and older adults from the re-examination phase of the Swedish prospective cohort Malmö Preventive Project (2002–2006). VTE events were collected using national registers until 31 December 2018. MetS was defined as the presence of three or more of the following factors: abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and... (More)
Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, including abdominal obesity, insulin resistance, dyslipidemia, and hypertension. Its association with venous thromboembolism (VTE) has been inconsistently reported. We investigated the association between MetS and VTE, and the influence of sex and abdominal obesity. We included 12,788 middle-aged and older adults from the re-examination phase of the Swedish prospective cohort Malmö Preventive Project (2002–2006). VTE events were collected using national registers until 31 December 2018. MetS was defined as the presence of three or more of the following factors: abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and impaired fasting glucose. During a mean follow-up of 11 years, 730 first VTE events occurred. The prevalence of MetS was higher in men than in women (p < 0.001). In analyses adjusted for age, height, and smoking, MetS was not associated with increased risk of VTE in men (HR 1.10; 95% CI 0.90–1.34) or women (HR 1.15; 95% CI 0.91–1.45). In women, higher VTE risk was found in those with multiple MetS factors compared to zero. Abdominal obesity was associated with VTE risk in women only (HR 1.80; 95% CI 1.43–2.27). MetS was not associated with VTE risk in men or women. The higher VTE risk observed with multiple MetS components in women appeared largely attributable to abdominal obesity, with little contribution from other components. Risk factors for VTE may differ by sex, with abdominal obesity appearing particularly relevant for women.
(Less)
- author
- Brodin, Niklas
LU
; Nymberg, Peter
LU
; Bolmsjö, Beata Borgström
LU
; Svensson, Peter J.
LU
; Elf, Johan
LU
; Zöller, Bengt
LU
and Calling, Susanna
LU
- organization
- publishing date
- 2026
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- Abdominal obesity, Deep vein thrombosis, Metabolic syndrome, Pulmonary embolism, Venous thromboembolism
- in
- Journal of Thrombosis and Thrombolysis
- publisher
- Springer
- external identifiers
-
- scopus:105033288794
- pmid:41790326
- ISSN
- 0929-5305
- DOI
- 10.1007/s11239-026-03255-x
- language
- English
- LU publication?
- yes
- additional info
- Publisher Copyright: © The Author(s) 2026.
- id
- e0ef1f32-7220-4146-8514-5db4d6545792
- date added to LUP
- 2026-04-18 16:27:49
- date last changed
- 2026-04-21 02:49:57
@article{e0ef1f32-7220-4146-8514-5db4d6545792,
abstract = {{<p>Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, including abdominal obesity, insulin resistance, dyslipidemia, and hypertension. Its association with venous thromboembolism (VTE) has been inconsistently reported. We investigated the association between MetS and VTE, and the influence of sex and abdominal obesity. We included 12,788 middle-aged and older adults from the re-examination phase of the Swedish prospective cohort Malmö Preventive Project (2002–2006). VTE events were collected using national registers until 31 December 2018. MetS was defined as the presence of three or more of the following factors: abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and impaired fasting glucose. During a mean follow-up of 11 years, 730 first VTE events occurred. The prevalence of MetS was higher in men than in women (p < 0.001). In analyses adjusted for age, height, and smoking, MetS was not associated with increased risk of VTE in men (HR 1.10; 95% CI 0.90–1.34) or women (HR 1.15; 95% CI 0.91–1.45). In women, higher VTE risk was found in those with multiple MetS factors compared to zero. Abdominal obesity was associated with VTE risk in women only (HR 1.80; 95% CI 1.43–2.27). MetS was not associated with VTE risk in men or women. The higher VTE risk observed with multiple MetS components in women appeared largely attributable to abdominal obesity, with little contribution from other components. Risk factors for VTE may differ by sex, with abdominal obesity appearing particularly relevant for women.</p>}},
author = {{Brodin, Niklas and Nymberg, Peter and Bolmsjö, Beata Borgström and Svensson, Peter J. and Elf, Johan and Zöller, Bengt and Calling, Susanna}},
issn = {{0929-5305}},
keywords = {{Abdominal obesity; Deep vein thrombosis; Metabolic syndrome; Pulmonary embolism; Venous thromboembolism}},
language = {{eng}},
publisher = {{Springer}},
series = {{Journal of Thrombosis and Thrombolysis}},
title = {{Metabolic syndrome and venous thromboembolism : the role of abdominal obesity and sex differences}},
url = {{http://dx.doi.org/10.1007/s11239-026-03255-x}},
doi = {{10.1007/s11239-026-03255-x}},
year = {{2026}},
}